Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-Bromo-2-cyanobenzoic acid is a chemical compound characterized by the molecular formula C8H4BrNO2. It is a white to off-white crystalline powder that exhibits solubility in organic solvents such as dichloromethane and dimethyl sulfoxide. 5-Bromo-2-cyanobenzoic acid is recognized for its role in organic synthesis and its potential applications in medicinal chemistry due to its anti-cancer and anti-inflammatory properties.

1032231-28-9

Post Buying Request

1032231-28-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1032231-28-9 Usage

Uses

Used in Organic Synthesis:
5-Bromo-2-cyanobenzoic acid is utilized as a key intermediate in the synthesis of various organic compounds, particularly for the production of pharmaceuticals and agrochemicals. Its unique structure allows it to serve as a versatile building block in the creation of a wide range of molecules with potential applications in different industries.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-Bromo-2-cyanobenzoic acid is used as a starting material for the development of new drugs. Its incorporation into drug molecules can enhance their therapeutic properties, making it a valuable component in the design and synthesis of novel pharmaceutical agents.
Used in Agrochemical Industry:
5-Bromo-2-cyanobenzoic acid is also employed in the agrochemical sector, where it is used in the synthesis of various agrochemicals. Its presence in these compounds can contribute to their effectiveness in agricultural applications, such as pest control and crop protection.
Used in Medicinal Chemistry Research:
5-Bromo-2-cyanobenzoic acid has been studied for its potential anti-cancer and anti-inflammatory properties, making it a subject of interest in medicinal chemistry research. Its ability to modulate biological pathways and exhibit therapeutic effects positions it as a promising candidate for the development of new treatments for various diseases.
Used in the Preparation of Heterocycles and Biologically Active Compounds:
5-Bromo-2-cyanobenzoic acid is used as a building block for the preparation of various heterocycles and biologically active compounds. Its structural features enable the formation of diverse molecular frameworks that can exhibit a range of biological activities, further expanding its utility in the field of chemistry and drug discovery.

Check Digit Verification of cas no

The CAS Registry Mumber 1032231-28-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,2,2,3 and 1 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1032231-28:
(9*1)+(8*0)+(7*3)+(6*2)+(5*2)+(4*3)+(3*1)+(2*2)+(1*8)=79
79 % 10 = 9
So 1032231-28-9 is a valid CAS Registry Number.

1032231-28-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Bromo-2-cyanobenzoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1032231-28-9 SDS

1032231-28-9Relevant articles and documents

C- ARYL GLYCOSID DERIVATIVES, PHARMACEUTICAL COMPOSITION, PREPARATION PROCESS AND USES THEREOF

-

Paragraph 0096; 0118; 0119; 0120, (2017/04/19)

This invention relates to a kind of C-aryl glycoside derivatives, its pharmaceutical compositions, preparation methods, and uses thereof. The preparation method comprises: method 1: in a solvent, deprotecting the acetyl protecting groups of compound 1-f in the presence of a base; method 2: 1) compound 2-g reacts with via Mitsunobu reaction; 2) deprotecting the acetyl protecting groups of compound 2-f obtained from step 1; method 3: 1) compound 2-g reacts with via nucleophilic substitution reaction; 2) deprotecting the acetyl protecting groups of compound 3-f obtained from step 1. The pharmaceutical composition comprises a kind of C-aryl glycoside derivatives; it's pharmaceutically acceptable salts and/or prodrugs thereof and excipient thereof. This invention further relates to a kind of C-aryl glycoside derivatives, it's pharmaceutically acceptable salts or pharmaceutical compositions thereof for the use in preparation of a SGLT inhibitor. The C-aryl glycoside derivatives of this invention provides a new direction for the study of SGLT inhibitors.

Regioselective generation of aryllithiums from substituted bromobenzenes XC6H4Br (X = 4-Br, 4-I, 4-CN, 2-CN)

Lulinski, Sergiusz,Serwatowski, Janusz,Szczerbinska, Magdalena

experimental part, p. 1797 - 1801 (2009/04/04)

Selected activated bromobenzenes XC6H4Br (X = 4-Br, 4-I, 4-CN, 2-CN) were successfully deprotonated with lithium 2,2,6,6-tetramethylpiperidide (LTMP) in THF at -80°C. Thus, 2,5-dibromo-, 2-bromo-5-iodo-, 5-bromo-2-cyano-, and 3-bromo

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1032231-28-9